Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by schmoo99on Dec 30, 2017 6:21pm

70 Views

Post# 27252479

RE:RE:Ban Greatwhite shark

LAWYERS WILL BE IN TOUCH WITH YOU SOON. YOU'VE BEEN REPORTED. Do you claim your rental income from your suite. That might be a can of worms for you if you publicly air that info. Won't be hard for Rev.Canada to track you down. Soon you will be shut down

Bullboard Posts

Understanding tax loss season and the “Santa Claus rally”